Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
基本信息
- 批准号:8372870
- 负责人:
- 金额:$ 62.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-20 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:Amniotic FluidAnimal ModelAntibiotic TherapyAntibioticsAttentional deficitAttenuatedAzithromycinBiochemical MarkersBiologicalBlood CirculationBrainBrain InjuriesCardiovascular PhysiologyCardiovascular systemCerebral PalsyCerebrospinal FluidCerebrumCharacteristicsChronicClinicalClinical ManagementCognitiveDataDevelopmentDinoprostDinoprostoneDiscipline of obstetricsDoppler UltrasonographyEncephalitisEvaluationExposure toFetal TherapiesFetusGenital systemHealthHumanHypoxiaImpairmentIncidenceIndolentInfantInfectionInfection of amniotic sac and membranesInfection preventionInflammationInflammatoryInflammatory ResponseInjuryInterleukin-6LifeLinkMacaca mulattaMacrolide AntibioticsMagnetic Resonance ImagingMedicineModalityModelingMonitorMycoplasmaNatureNeonatalNeonatal Brain InjuryNeonatal MortalityNeurodevelopmental DisabilityNeurodevelopmental ImpairmentNeurologicNeuronal InjuryOligodendrogliaOutcomePerinatalPerinatal ExposurePeriventricular LeukomalaciaPeriventricular white matter injuryPregnancyPremature BirthPremature InfantPremature LaborPreventionPrimatesProbabilityProlonged PregnancyPublic HealthReportingResearch DesignResearch ProposalsResourcesRespiratory SystemRespiratory tract structureRiskSamplingSeveritiesSignal TransductionSimulateStagingTNF geneTherapeutic EffectTherapeutic InterventionTimeTranslatingUmbilical Cord BloodUreaplasmaUreaplasma InfectionsWhite Blood Cell Count procedureamniotic cavityastrogliosiscentral nervous system injuryclinical applicationcritical periodcytokinedesigndisabilityfetalfollow-uphemodynamicsimprovedin uteroindexinginsightintraamniotic infectionmicroorganismmultidisciplinaryneonatal morbidityneonateneurobehavioralneurodevelopmentneuromuscularnonhuman primatenovelnovel strategiespathogenpostnatalprenatalpreventprognostic indicatorresponsetreatment strategyuterine contractilitywhite matterwhite matter damagewhite matter injury
项目摘要
DESCRIPTION (provided by applicant): The objectives of this research proposal are to assess the therapeutic effect of antenatal maternal antibiotic therapy in preventing or mollifying cerebral white matter damage in the neonate (as a consequence of prolonged U.parvum intra-amniotic infection, IAI) and to correlate neurobehavioral outcomes with neuropathologic findings of neonatal brain injury. Our central hypothesis is that prenatal treatment of prolonged U.parvum IAI with a specific macrolide antibiotic, azithromycin (AZI) will mitigate fetal origins of cerebra white matter injury and decrease the severity of perinatal neurological impairment. The experimental approach will utilize our non-human primate model of IAI, with mid-gestation inoculation of U.parvum (105 CFU/ml, serovar 1) at 105 days gestation. We predict our new approach will mimic the indolent nature of Ureaplasma spp. infections during human pregnancies by prolonging fetal exposure to these microorganisms and the resultant inflammatory milieu, with the potential for intensified periventricular white matter injury. Fetal cardiovascular hemodynamic and regional circulatory changes in response to prolonged U.parvum IAI, and maternal antenatal therapy, will be monitored by Doppler ultrasonography and linked with magnetic resonance imaging (MRI) of the fetal brain during critical periods of development. Serial MRI scans of fetal (in utero) and infant brains will provide insight into the nature and timing of potential white matter injury occurring during U.parvum IAI and in the neonatal period. Postnatal follow-up studies are designed to correlate adverse neurodevelopmental outcomes such as dysfunctional neuromuscular dexterity, neurobehavioral and cognitive abnormalities with neuropathologic findings of chronic perinatal white matter inflammation (i.e., microgliosis, astrogliosis & arrested oligodendrocyte maturation). A number of mechanistic endpoints will be ascertained that will aid in our understanding of the causal links among Ureaplasma infections, fetal inflammatory responses, and hemodynamic adaptations which portend cerebral white matter damage and neurological disabilities. Biochemical markers characteristic of the fetal inflammatory response, i.e., amniotic fluid levels of PGE2, PGF2¿, pro-inflammatory cytokines (IL-6, TNF-¿, IL-1¿), total leukocyte counts and uterine contractility will be correlated with quantitative culture & PCR for U.parvum from the amniotic fluid, fetal cord blood and neonatal samples, in order to establish prognostic indicators of antibiotic therapy which may help improve clinical management decisions. A major strength of our application lies in our ability to incorporate an "in utero" treatment strategy to prevent adverse neurologic sequelae with postnatal functional assessments of neurobehavioral and cognitive development in a unique and relevant animal model. Given the confluence of resources and expertise of our multidisciplinary investigative team, our scientific approach has a high probability of translating
to clinical applications which will reduce adverse neurologic sequelae in prematurely born human infants.]
PUBLIC HEALTH RELEVANCE: Intra-amniotic infection by genital Mycoplasmas (i.e., Ureaplasma spp.) is a predominant cause of early preterm birth; arguably the most important unresolved public health issue in obstetric medicine. Preterm infants often have life-long health complications including neurodevelopmental disabilities such as cerebral palsy. This proposal will expand our understanding of the causal relationships among intra-amniotic Ureaplasma infections, fetal brain injury and adverse neurological development in the preterm neonate.
描述:这项研究建议的目标是在预防或在新生儿中进行脑白质损害的治疗方法,并将神经行为与新生儿脑损伤的神经病理学与神经病理学相关联。大型抗生素,阿奇霉素(AZI)将减轻胎儿的起源,围绕围产期神经病学障碍的严重程度。尿素质量属于人类延长的胎儿中的无菌,并导致脑静脉内造成的腹膜和母体产前治疗,并伴有磁性疾病。成像(MRI)l发育时期。慢性围产期白质炎症(即,小胶质细胞增多,星形胶质细胞增多症和少突胶质细胞成熟)。 » ,pro-il-6,tnf-¿建立抗生素的编程器,可以帮助改善临床管理决策。
对于临床应用,可以减少过早出生的人类婴儿中不良神经系统的后遗症。]
公共卫生的相关性:生殖器菌落中的肿瘤内感染在产科医学中遭受了不良的公共卫生问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peta Louise Grigsby其他文献
Peta Louise Grigsby的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peta Louise Grigsby', 18)}}的其他基金
Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
- 批准号:
8666013 - 财政年份:2012
- 资助金额:
$ 62.17万 - 项目类别:
Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
- 批准号:
9065594 - 财政年份:2012
- 资助金额:
$ 62.17万 - 项目类别:
Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
- 批准号:
8532944 - 财政年份:2012
- 资助金额:
$ 62.17万 - 项目类别:
UREAPLASMA INVASION OF CHORION AND AMNION EPITHELIAL CELL LAYERS IN VITRO
体外解脲支原体对绒毛膜和羊膜上皮细胞层的侵袭
- 批准号:
8357846 - 财政年份:2011
- 资助金额:
$ 62.17万 - 项目类别:
UREAPLASMA INFECTION IN UTERO: PREVENTION OF NEUROLOGIC SEQUELAE
子宫内脲原体感染:预防神经系统后遗症
- 批准号:
8357809 - 财政年份:2011
- 资助金额:
$ 62.17万 - 项目类别:
COMPARTMENTAL ANALYSIS OF PROTEOMIC BIOMARKERS DURING INTRA-UTERINE INFECTIONS
子宫内感染期间蛋白质组生物标志物的区室分析
- 批准号:
8357791 - 财政年份:2011
- 资助金额:
$ 62.17万 - 项目类别:
COMPARTMENTAL ANALYSIS OF PROTEOMIC BIOMARKERS DURING INTRA-UTERINE INFECTIONS
子宫内感染期间蛋白质组生物标志物的区室分析
- 批准号:
8173276 - 财政年份:2010
- 资助金额:
$ 62.17万 - 项目类别:
UREAPLASMA INFECTION IN UTERO: PREVENTION OF NEUROLOGIC SEQUELAE
子宫内脲原体感染:预防神经系统后遗症
- 批准号:
8173301 - 财政年份:2010
- 资助金额:
$ 62.17万 - 项目类别:
COMPARTMENTAL ANALYSIS OF PROTEOMIC BIOMARKERS DURING INTRA-UTERINE INFECTIONS
子宫内感染期间蛋白质组生物标志物的区室分析
- 批准号:
7958555 - 财政年份:2009
- 资助金额:
$ 62.17万 - 项目类别:
PLACENTAL PLASTICITY, FETAL GROWTH AND DEVELOPMENTAL PROGRAMMING
胎盘可塑性、胎儿生长和发育规划
- 批准号:
7958484 - 财政年份:2009
- 资助金额:
$ 62.17万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
利用肝癌动物模型开展化学可控的在体基因编辑体系的研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
- 批准号:
8666013 - 财政年份:2012
- 资助金额:
$ 62.17万 - 项目类别:
Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
- 批准号:
9065594 - 财政年份:2012
- 资助金额:
$ 62.17万 - 项目类别:
Primate model of mid-gestation Ureaplasma in utero infection: Prevention of neuro
妊娠中期解脲支原体宫内感染的灵长类动物模型:神经系统疾病的预防
- 批准号:
8532944 - 财政年份:2012
- 资助金额:
$ 62.17万 - 项目类别: